Beijing Biocytogen has established a high throughput monoclonal antibody production platform with experienced scientists and advanced equipment. Based on our novel hybridoma technology integrated with all related resources, this robust monoclonal antibody production platform will better serve the field of immuno-oncology research.
The Preparation Process of Monoclonal Antibody
iQue Screener PLUS Platform GE AKTA avant 150 Chromatography System
Biacore T200 Biacore8K System